TLRY
TLRY
Tilray Brands, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $282.2M ▼ | $102.14M ▼ | $-36.27M ▲ | -12.85% ▲ | $-0.33 ▲ | $-2.12M ▲ |
| Q2-2026 | $303.85M ▲ | $111.45M ▲ | $-62.77M ▼ | -20.66% ▼ | $-0.57 ▼ | $-26.03M ▼ |
| Q1-2026 | $287.78M ▼ | $76.07M ▼ | $-442.31K ▲ | -0.15% ▲ | $-0 ▲ | $29.51M ▲ |
| Q4-2025 | $308.1M ▲ | $2.07B ▲ | $-1.75B ▼ | -566.86% ▼ | $-17.8 ▼ | $-1.84B ▼ |
| Q3-2025 | $268.34M | $1.17B | $-1.14B | -424.93% | $-12.6 | $-1.08B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $219.93M ▼ | $2.07B ▼ | $549.12M ▼ | $1.56B ▼ |
| Q2-2026 | $407.29M ▲ | $2.93B ▲ | $771.26M ▼ | $2.21B ▲ |
| Q1-2026 | $363.78M ▲ | $2.86B ▼ | $771.97M ▼ | $2.12B ▲ |
| Q4-2025 | $351.78M ▼ | $2.9B ▼ | $860.49M ▼ | $2.07B ▼ |
| Q3-2025 | $358.81M | $4.92B | $1.01B | $3.94B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $-25.23M ▲ | $-22.15M ▼ | $28.63M ▲ | $-4.31M ▼ | $2.8M ▲ | $-26.02M ▼ |
| Q2-2026 | $-60.78M ▼ | $-11.93M ▼ | $-81.03M ▼ | $67.19M ▲ | $-25.32M ▼ | $-25.47M ▼ |
| Q1-2026 | $2.08M ▲ | $-1.84M ▲ | $33.61M ▲ | $27.26M ▲ | $59.29M ▲ | $-14.92M ▲ |
| Q4-2025 | $-1.75B ▼ | $-19.86M ▼ | $16.62M ▲ | $26.12M ▲ | $29.79M ▲ | $-29.27M ▼ |
| Q3-2025 | $-1.14B | $-5.09M | $2.2M | $21.45M | $14.82M | $-24.81M |
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Beverage Alcohol Business | $70.00M ▲ | $60.00M ▼ | $50.00M ▼ | $40.00M ▼ |
Cannabis Segment | $90.00M ▲ | $90.00M ▲ | $90.00M ▲ | $80.00M ▼ |
Distribution Revenue | $70.00M ▲ | $70.00M ▲ | $90.00M ▲ | $80.00M ▼ |
Wellness Business | $20.00M ▲ | $20.00M ▲ | $10.00M ▼ | $20.00M ▲ |
Revenue by Geography
| Region | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
CANADA | $50.00M ▲ | $60.00M ▲ | $50.00M ▼ | $50.00M ▲ |
EMEA | $90.00M ▲ | $90.00M ▲ | $100.00M ▲ | $100.00M ▲ |
Rest of World | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $70.00M ▲ | $60.00M ▼ | $60.00M ▲ | $50.00M ▼ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Tilray Brands, Inc.'s financial evolution and strategic trajectory over the past five years.
Tilray’s main strengths are its growing revenue base, improving gross margins, and diversified business model that spans cannabis, beverages, wellness, and distribution across multiple geographies. It holds leading positions in several markets, including Canadian recreational cannabis, cannabis beverages, and European medical cannabis, and it has a notable foothold in U.S. craft beer. The balance sheet, while weakened, still shows acceptable liquidity and reduced debt levels, and capital spending has been kept under control. The company also benefits from meaningful experience navigating complex regulations and from a visible innovation agenda in cultivation technology and product development.
The most significant risks are financial. Net losses, operating losses, and cash burn are all very large and have been worsening rather than improving, leading to sharply negative margins and a heavy reliance on equity issuance. Asset impairments and cumulative losses have severely eroded shareholder equity, and retained earnings are deeply negative. If losses and negative free cash flow persist, access to capital could become more difficult or more dilutive. Operationally, high overhead, reduced formal R&D investment, and the challenge of integrating and managing diverse businesses (cannabis, beverages, wellness) all add execution risk. Industry-specific risks—regulatory uncertainty, pricing pressure, and strong competition—further complicate the picture.
The outlook for Tilray is highly dependent on two factors: its ability to bring costs under control and move toward sustainable positive cash flow, and how global cannabis and related regulations evolve, particularly in the United States. The company has built a strategic platform with real market presence and clear optionality if legalization trends continue, which creates upside potential if execution improves. However, current financial trends are unfavorable, and turning the business from a scale-driven growth story into a profitable, self-funding enterprise will likely require significant restructuring, discipline, and time. Overall, the strategic positioning is promising, but the financial and operational path to realizing that promise is challenging and uncertain.
About Tilray Brands, Inc.
https://www.tilray.comTilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $282.2M ▼ | $102.14M ▼ | $-36.27M ▲ | -12.85% ▲ | $-0.33 ▲ | $-2.12M ▲ |
| Q2-2026 | $303.85M ▲ | $111.45M ▲ | $-62.77M ▼ | -20.66% ▼ | $-0.57 ▼ | $-26.03M ▼ |
| Q1-2026 | $287.78M ▼ | $76.07M ▼ | $-442.31K ▲ | -0.15% ▲ | $-0 ▲ | $29.51M ▲ |
| Q4-2025 | $308.1M ▲ | $2.07B ▲ | $-1.75B ▼ | -566.86% ▼ | $-17.8 ▼ | $-1.84B ▼ |
| Q3-2025 | $268.34M | $1.17B | $-1.14B | -424.93% | $-12.6 | $-1.08B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $219.93M ▼ | $2.07B ▼ | $549.12M ▼ | $1.56B ▼ |
| Q2-2026 | $407.29M ▲ | $2.93B ▲ | $771.26M ▼ | $2.21B ▲ |
| Q1-2026 | $363.78M ▲ | $2.86B ▼ | $771.97M ▼ | $2.12B ▲ |
| Q4-2025 | $351.78M ▼ | $2.9B ▼ | $860.49M ▼ | $2.07B ▼ |
| Q3-2025 | $358.81M | $4.92B | $1.01B | $3.94B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $-25.23M ▲ | $-22.15M ▼ | $28.63M ▲ | $-4.31M ▼ | $2.8M ▲ | $-26.02M ▼ |
| Q2-2026 | $-60.78M ▼ | $-11.93M ▼ | $-81.03M ▼ | $67.19M ▲ | $-25.32M ▼ | $-25.47M ▼ |
| Q1-2026 | $2.08M ▲ | $-1.84M ▲ | $33.61M ▲ | $27.26M ▲ | $59.29M ▲ | $-14.92M ▲ |
| Q4-2025 | $-1.75B ▼ | $-19.86M ▼ | $16.62M ▲ | $26.12M ▲ | $29.79M ▲ | $-29.27M ▼ |
| Q3-2025 | $-1.14B | $-5.09M | $2.2M | $21.45M | $14.82M | $-24.81M |
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Beverage Alcohol Business | $70.00M ▲ | $60.00M ▼ | $50.00M ▼ | $40.00M ▼ |
Cannabis Segment | $90.00M ▲ | $90.00M ▲ | $90.00M ▲ | $80.00M ▼ |
Distribution Revenue | $70.00M ▲ | $70.00M ▲ | $90.00M ▲ | $80.00M ▼ |
Wellness Business | $20.00M ▲ | $20.00M ▲ | $10.00M ▼ | $20.00M ▲ |
Revenue by Geography
| Region | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
CANADA | $50.00M ▲ | $60.00M ▲ | $50.00M ▼ | $50.00M ▲ |
EMEA | $90.00M ▲ | $90.00M ▲ | $100.00M ▲ | $100.00M ▲ |
Rest of World | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $70.00M ▲ | $60.00M ▼ | $60.00M ▲ | $50.00M ▼ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Tilray Brands, Inc.'s financial evolution and strategic trajectory over the past five years.
Tilray’s main strengths are its growing revenue base, improving gross margins, and diversified business model that spans cannabis, beverages, wellness, and distribution across multiple geographies. It holds leading positions in several markets, including Canadian recreational cannabis, cannabis beverages, and European medical cannabis, and it has a notable foothold in U.S. craft beer. The balance sheet, while weakened, still shows acceptable liquidity and reduced debt levels, and capital spending has been kept under control. The company also benefits from meaningful experience navigating complex regulations and from a visible innovation agenda in cultivation technology and product development.
The most significant risks are financial. Net losses, operating losses, and cash burn are all very large and have been worsening rather than improving, leading to sharply negative margins and a heavy reliance on equity issuance. Asset impairments and cumulative losses have severely eroded shareholder equity, and retained earnings are deeply negative. If losses and negative free cash flow persist, access to capital could become more difficult or more dilutive. Operationally, high overhead, reduced formal R&D investment, and the challenge of integrating and managing diverse businesses (cannabis, beverages, wellness) all add execution risk. Industry-specific risks—regulatory uncertainty, pricing pressure, and strong competition—further complicate the picture.
The outlook for Tilray is highly dependent on two factors: its ability to bring costs under control and move toward sustainable positive cash flow, and how global cannabis and related regulations evolve, particularly in the United States. The company has built a strategic platform with real market presence and clear optionality if legalization trends continue, which creates upside potential if execution improves. However, current financial trends are unfavorable, and turning the business from a scale-driven growth story into a profitable, self-funding enterprise will likely require significant restructuring, discipline, and time. Overall, the strategic positioning is promising, but the financial and operational path to realizing that promise is challenging and uncertain.

CEO
Irwin David Simon
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-12-02 | Reverse | 1:10 |
| 2021-05-03 | Reverse | 8381:10000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 42
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
TOROSO INVESTMENTS, LLC
Shares:26.13M
Value:$179.26M
HRT FINANCIAL LP
Shares:14.85M
Value:$101.87M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:10.13M
Value:$69.47M
Summary
Showing Top 3 of 443

